Market Overview:
The global beta-hydroxybutyrate testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of diabetes and obesity, rising awareness about early diagnosis and treatment of diabetes, and technological advancements in beta-hydroxybutyrate testing devices. Based on type, the global beta-hydroxybutyrate testing market is segmented into urine ketones and blood glucose levels. The urine ketones segment is expected to account for the majority share of the global beta-hydroxybutyrate testing market in 2018. This segment is projected to grow at a CAGR of 8% from 2018 to 2030 due to increasing incidence of diabetes worldwide. Based on application, the global beta-hydroxybutyrate testing market is divided into hospitals, clinics, diagnostic laboratories, and home care settings. The hospitals segment accounted for the majority share of this market in 2017 owing to rising number of hospital admissions for patients with diabetes mellitus across regions.
Product Definition:
Beta-Hydroxybutyrate testing is a blood test that is used to measure the level of beta-hydroxybutyrate in the blood. Beta-hydroxybutyrate is a ketone body that is produced when the body breaks down fat for energy. Measuring the level of beta-hydroxybutyrate in the blood can help doctors determine if a person has ketosis, which is a condition caused by too little insulin and high levels of sugar in the blood.
Urine Ketones:
Urine ketones are body byproducts that are produced as a result of fat metabolism. Urine ketone test is used to detect the level of Ketone bodies in the patient's urine. The normal range for blood Ketone levels is 0.5 - 3mmol/L and urine ketones should be less than 5mmol/L, if they remain higher than that then it indicates a problem with fat metabolism and thus urinary tract or liver disease may be diagnosed.
Blood Glucose Levels:
Blood glucose levels are used in beta-hydroxybutyrate (GHB) testing market. GHB is an organic compound that is naturally produced by the human body and found in breast milk. It plays a significant role as a metabolic intermediate during sleep, feeding, and aerobic activity. The primary functions of blood glucose levels are to provide energy to the cells and maintain the fluid balance across cellular membranes.
Application Insights:
The market is segmented based on application into hospitals, clinics, diagnostic laboratories and home care. Hospitals held the largest share of over 70.0% in 2017 owing to the presence of a large patient base with diabetes at hospitals that require frequent monitoring for maintaining optimum glycemic control. Beta-hydroxybutyrate testing is also carried out frequently in patients admitted with ketoacidosis as part of routine medical management procedures at hospitals.
Clinics are expected to witness lucrative growth over the forecast period due to an increase in demand for advanced diagnostics testing options that provide rapid results without requiring multiple blood draws or physical examinations by healthcare professionals or patients themselves at home.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increasing prevalence of obesity and diabetes, rising awareness about BHB testing, and availability of advanced technologies for its use. Moreover, government initiatives promoting healthy lifestyles are expected to drive demand for products over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness levels regarding available diagnostic methods. In addition, a rise in disposable income is anticipated to boost demand for medical tests that require beta-hydroxybutyrate testing over the next eight years.
Growth Factors:
- Increasing awareness about the benefits of beta-hydroxybutyrate testing among consumers and healthcare professionals.
- Growing demand for personalized medicine and targeted therapies.
- Rising prevalence of chronic diseases such as diabetes, obesity, and cardiovascular diseases.
- Technological advancements in beta-hydroxybutyrate testing methods and devices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Beta-Hydroxybutyrate Testing Market Research Report
By Type
Urine Ketones, Blood Glucose Levels
By Application
Hospitals, Clinics, Diagnostic Laboratories, Home Care
By Companies
EKF Diagnostics, Abcam plc, Merck KGaA, Randox Laboratories Ltd, Cayman Chemical, Quest Diagnostics, AAT Bioquest, Inc, Abnova Corporation, AAT Bioquest, Inc, BioAssay Systems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Beta-Hydroxybutyrate Testing Market Report Segments:
The global Beta-Hydroxybutyrate Testing market is segmented on the basis of:
Types
Urine Ketones, Blood Glucose Levels
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Laboratories, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EKF Diagnostics
- Abcam plc
- Merck KGaA
- Randox Laboratories Ltd
- Cayman Chemical
- Quest Diagnostics
- AAT Bioquest, Inc
- Abnova Corporation
- AAT Bioquest, Inc
- BioAssay Systems
Highlights of The Beta-Hydroxybutyrate Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Urine Ketones
- Blood Glucose Levels
- By Application:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Beta-Hydroxybutyrate Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Beta-hydroxybutyrate (BHB) is a ketone body produced when the body breaks down fatty acids. BHB can be used as an energy source, and has been shown to improve mental clarity and focus.
Some of the major companies in the beta-hydroxybutyrate testing market are EKF Diagnostics, Abcam plc, Merck KGaA, Randox Laboratories Ltd, Cayman Chemical, Quest Diagnostics, AAT Bioquest, Inc, Abnova Corporation, AAT Bioquest, Inc, BioAssay Systems.
The beta-hydroxybutyrate testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Beta-Hydroxybutyrate Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Beta-Hydroxybutyrate Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Beta-Hydroxybutyrate Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Beta-Hydroxybutyrate Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Beta-Hydroxybutyrate Testing Market Size & Forecast, 2018-2028
4.5.1 Beta-Hydroxybutyrate Testing Market Size and Y-o-Y Growth
4.5.2 Beta-Hydroxybutyrate Testing Market Absolute $ Opportunity
Chapter 5 Global Beta-Hydroxybutyrate Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Beta-Hydroxybutyrate Testing Market Size Forecast by Type
5.2.1 Urine Ketones
5.2.2 Blood Glucose Levels
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Beta-Hydroxybutyrate Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Beta-Hydroxybutyrate Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Laboratories
6.2.4 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Beta-Hydroxybutyrate Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Beta-Hydroxybutyrate Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Beta-Hydroxybutyrate Testing Analysis and Forecast
9.1 Introduction
9.2 North America Beta-Hydroxybutyrate Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Beta-Hydroxybutyrate Testing Market Size Forecast by Type
9.6.1 Urine Ketones
9.6.2 Blood Glucose Levels
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Beta-Hydroxybutyrate Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Laboratories
9.10.4 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Beta-Hydroxybutyrate Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Beta-Hydroxybutyrate Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Beta-Hydroxybutyrate Testing Market Size Forecast by Type
10.6.1 Urine Ketones
10.6.2 Blood Glucose Levels
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Beta-Hydroxybutyrate Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Laboratories
10.10.4 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Beta-Hydroxybutyrate Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Beta-Hydroxybutyrate Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Beta-Hydroxybutyrate Testing Market Size Forecast by Type
11.6.1 Urine Ketones
11.6.2 Blood Glucose Levels
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Beta-Hydroxybutyrate Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Laboratories
11.10.4 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Beta-Hydroxybutyrate Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Beta-Hydroxybutyrate Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Beta-Hydroxybutyrate Testing Market Size Forecast by Type
12.6.1 Urine Ketones
12.6.2 Blood Glucose Levels
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Beta-Hydroxybutyrate Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Laboratories
12.10.4 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Beta-Hydroxybutyrate Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Beta-Hydroxybutyrate Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Beta-Hydroxybutyrate Testing Market Size Forecast by Type
13.6.1 Urine Ketones
13.6.2 Blood Glucose Levels
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Beta-Hydroxybutyrate Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Laboratories
13.10.4 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Beta-Hydroxybutyrate Testing Market: Competitive Dashboard
14.2 Global Beta-Hydroxybutyrate Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EKF Diagnostics
14.3.2 Abcam plc
14.3.3 Merck KGaA
14.3.4 Randox Laboratories Ltd
14.3.5 Cayman Chemical
14.3.6 Quest Diagnostics
14.3.7 AAT Bioquest, Inc
14.3.8 Abnova Corporation
14.3.9 AAT Bioquest, Inc
14.3.10 BioAssay Systems
